Nanomedicine for cancer therapy using Autophagy: An Overview

(E-pub Abstract Ahead of Print)

Author(s): Rajesh Kotcherlakota, Syed Tazib Rahaman, Chitta Ranjan Patra*.

Journal Name: Current Topics in Medicinal Chemistry


Autophagy is an intracellular biological catabolic process of mammalian cells to maintain the homeostasis. It plays a wide role in the clearance of damaged cellular organelles, misfolded or aggregated proteins like alpha synuclein, β-amyloid peptides and tau etc. and pathogens. Recent studies have clearly demonstrated that dysfunction in autophagy leads to the development of cancer, cardiomyopathy, chronic infection, neurodegenerative and other diseases. Therefore, modulation of autophagy has therapeutic value to cure the diseases including cancer using external stimuli. In this context, various researchers developed small molecules such as chloroquine, rapamycin etc. for the treatment of cancer through autophagy. However, these molecules possess side effects which limit their use in the clinics. Therefore, nanomedicine approach could stand as alternative treatment option to induce the autophagy in cancer therapy. Several investigators developed variety of nanomaterials which themself act as autophagy inducers or inhibitors. Considering this, the present review article will focus on the recent developments of nanomedicine in the area of autophagy that have been focused for the treatment of cancers. We also summarised the detailed mechanisms of nanoparticles mediated autophagy which could be helpful for developing new strategies to fight against cancer. Also, the present review article covers the current clinical status of nanomedicine and future challenges. Finally, we conclude with the future potential role of nanomedicine for autophagy induction in the cancer treatment.

Keywords: Cancer, nanomedicine, autophagy, eukaryotic cell, lysosome.

Rights & PermissionsPrintExport Cite as

Article Details

(E-pub Abstract Ahead of Print)
DOI: 10.2174/1568026619666181224104838
Price: $95